Patents

Publications

Latest News

Patents

The Proposed EU SEP Regulation: a new ecosystem in SEP licensing?

Last April, the European Commission presented three regulatory proposals arising out of the IP Action Plan adopted in November 2020, which we discussed in a previous publication (https://vidalquadrasramon.com/en/essentiality-assessment-of-seps-and-plans-of-the-commission/). One of such proposals relates to standard-essential patents (SEPs).  Technical standards implemented worldwide, such as those relating to the different generations of mobile phone technologies (2G to ...

Publications

Latest News

Patents

Always seek the court’s permission before requesting the limitation of the patent outside the judicial proceeding: the tiotropium case

On 9 February 2023 the Supreme Court upheld a Judgment issued by the Barcelona Provincial Court (Section 15th, specializing in intellectual property matters) which confirmed the nullity of a patent as limited in the court proceedings and ruled that another limitation requested by the proprietor outside them was not valid. The Supreme Court Judgment is ...

Publications

Latest News

Publications

Latest News

Publications

Latest News

Patents

Green light to the UPCA: a failure for the European Union

Last Friday 17 February 2023 was a sad day for the EU. Germany decided to ratify a treaty that shatters the hope of one day having an EU patent law. The decision to accept a court promoted by certain lobbies was ratified. A special court that deprives the Court of Justice of the European Union ...

Publications

Latest News

Patents

Sorafenib case: the alleged legal presumption of validity of the patent admits evidence to the contrary in injunctive relief proceedings

[et_pb_section fb_built=”1″ _builder_version=”3.19.5″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”2_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_image src=”https://vidalquadrasramon.com/wp-content/uploads/2022/10/drugs-2.jpg” _builder_version=”3.19.5″][/et_pb_image][/et_pb_column][et_pb_column type=”3_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_post_title comments=”off” featured_image=”off” _builder_version=”3.19.5″ title_level=”h4″ title_font=”||||||||”][/et_pb_post_title][et_pb_text _builder_version=”3.19.5″] In this brief note we refer to the Order of the Barcelona Provincial Court (15th Section) 59/2022 of 22 April, which confirmed the Order of the Barcelona Commercial Court No. 1 of ...

Publications

Latest News

Patents

SPC manufacturing waiver: ten essential tips

On 2 July 2022, the SPC manufacturing waiver, approved by EU Regulation 2019/933, came into effect. This regulation is one of the most important initiatives developed in Europe for the pharmaceutical industry that manufactures its products in the European Union. To understand the importance of this regulation, we must take into account that 24% of ...

Publications

Latest News

Patents

The extension of protection during the patent examination in infringement proceedings (the Lékué case)

[et_pb_section fb_built=”1″ _builder_version=”3.19.5″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”2_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_image src=”https://vidalquadrasramon.com/wp-content/uploads/2022/07/VQR_LAW_21.07.22-1.jpg” _builder_version=”3.19.5″][/et_pb_image][/et_pb_column][et_pb_column type=”3_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_post_title comments=”off” featured_image=”off” _builder_version=”3.19.5″][/et_pb_post_title][et_pb_text _builder_version=”3.19.5″] The Judgment of the Barcelona Court of Appeals (15th Section) of 30 March 2022 (ECLI:ES:APB:2022:3220) upholds the appeal against the Judgment handed down by Commercial Court No. 4 of Barcelona in a case for ...

Publications

Latest News

Patents

Reformulation of the objective technical problem and plausibility in a patent case in Spain (cinacalcet case)

In this commentary we will refer to the Judgment of the Barcelona Provincial Court (15th Section) 1610/2021 of 27 July (ECLI:ES:APB:2021:8276). We do not intend to provide a critical commentary on the Judgment, but simply to refer to some aspects that we have considered to be of interest in patent matters and, in particular, to the legal analysis of the plausibility of a technical effect on which the inventive step of patent EP 1 203 761 (EP'761) was based. This was the CCP's basic patent on the product cinacalcet.

Publications

Latest News

VQR IPSTARS
WHO'S WHO LEGAL